The PGA Tour announced a six-month suspension for Trey Mullinax on Wednesday after the 34-year-old tested positive for performance-enhancing drugs, violating the Tour's anti-doping policy.
Mullinax co-operated with the process and accepted the suspension, the Tour confirmed. He released a statement explaining the positive test.
Mullinax's Statement
"To my fans, I want to address the news regarding my failed anti-doping test and the suspension that followed. I take full responsibility for what happened," Mullinax said. "At the end of the day, it is my responsibility to understand and follow the PGA TOUR's Anti-Doping Policy and all of its rules and regulations. I failed to do that, and that is on me."
He explained that he had used a medication to treat a condition diagnosed in college without seeking approval under the policy. "My lack of knowledge is not an excuse. It was my responsibility to know the rules before taking any medication and I failed to do so. I want to be absolutely clear - I have never taken any substance with the intention of gaining a competitive advantage."
Mullinax added: "Anyone who knows me knows how much I respect this game and the values it represents. I accept the consequences of my actions and will use this experience as a lesson. Golf has given me so much, and I never want one mistake to define the respect I have for the game or for the people who support me. Thank you to everyone who has supported me, and I look forward to competing again in 2027."
Impact on Career
Because of his suspension, Mullinax will be unable to play until January, which will likely cause him to drop from his world ranking of No. 77. He has one PGA Tour victory and one top-10 finish at a major championship, achieved at the 2017 US Open.
His most recent tournament appearance was at the Zurich Classic of New Orleans in late April. He has played three events this spring, including one Korn Ferry event, a competition he has won twice.
